Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Détails bibliographiques
Auteur principal: Akter, Anika
Autres auteurs: Alam, Marzia
Format: Thèse
Langue:English
Publié: Brac University 2022
Sujets:
TNF-alpha
Rheumatoid arthritis
Biologics
Biosimilars
Adalimumab
ABP-501
Pharmacokinetics
Immunogenicity
Plaque psoriasis
Inflammation
Immunity
Accès en ligne:http://hdl.handle.net/10361/17039

Internet

http://hdl.handle.net/10361/17039

Documents similaires